Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease ...Middle East

Medscape - News
The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and returned to its baseline level by around 10 weeks. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease )

Also on site :